Thioketal-Incorporated Biodegradable Lipid Nanoparticles Deliver mRNA to Ductal Epithelial Cells for Improved Pancreatic Cancer Treatment
Journal of the American Chemical Society · 2025
DOI: 10.1021/jacs.5c19387 ↗At a glance
Journal article in Journal of the American Chemical Society, 2025. Written by Xinyu Qiu and 7 co-authors. Institution: Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Frontiers Science Center for New Organic Mat…. Major MEDLINE topics: RNA, Messenger, Nanoparticles, Pancreatic Neoplasms, Lipids. Cited 15 times so far (Crossref); 75 references. Funded by: Nankai University, National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (original language)
Delivery of mRNA to the ductal epithelial cells remains a formidable challenge but holds substantial potential for pancreatic ductal adenocarcinoma (PDAC) treatment. Herein, for the first time, we report a new class of thioketal-incorporated biodegradable ionizable lipids (TBILs) for potent mRNA delivery to the pancreas and ductal epithelial cells. 4A2-B8-PH, featuring four thioketal-bridged linkers, was identified as the optimal candidate, which possesses superior endosomal escape and mRNA release abilities. Unlike thioketal-free LNPs that mediated widespread mRNA expression across multiple organs following intraperitoneal administration, 4A2-B8-PH LNPs exclusively delivered mRNA to the pancreas with 98.3% targeting specificity. Furthermore, 4A2-B8-PH LNPs demonstrated significantly higher mRNA delivery efficiency to pancreatic tissue, surpassing those previous pancreas-targeted LNP benchmarks by 2 orders of magnitude. Notably, our optimized LNPs achieved robust mRNA expression in pancreatic ductal epithelial cells, transfecting 30.5% of the target cell population. More encouragingly, administration of 4A2-B8-PH LNPs encapsulating interleukin-12 (IL-12) mRNA induced complete tumor eradication in an orthotopic PDAC mouse model while avoiding systemic off-target toxicity. Collectively, this work paves the way for advancing the development of pancreas-targeted LNPs, as well as addresses the challenge of efficient mRNA delivery to ductal epithelial cells for treating intractable pancreatic diseases.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Research Center for Analytical Sciences, Tianjin Key Laboratory of Biosensing and Molecular Recognition, Frontiers Science Center for New Organic Matter, College of Chemistry, Nankai University, Tianjin 300071, China.
ORCID profiles: Hu Xiong
Funding
- Nankai University
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Cite
APA
Qiu, X., Yang, Y., Ma, Q., Zheng, B., Chen, Z., Wu, F., Zhou, B., & Xiong, H. (2025). Thioketal-Incorporated Biodegradable Lipid Nanoparticles Deliver mRNA to Ductal Epithelial Cells for Improved Pancreatic Cancer Treatment. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c19387
Vancouver
Qiu X, Yang Y, Ma Q, Zheng B, Chen Z, Wu F, et al. Thioketal-Incorporated Biodegradable Lipid Nanoparticles Deliver mRNA to Ductal Epithelial Cells for Improved Pancreatic Cancer Treatment. Journal of the American Chemical Society. 2025. doi:10.1021/jacs.5c19387
BibTeX
@article{Qiu2025,
author = {Qiu, Xinyu and Yang, Yuexia and Ma, Qian and Zheng, Bingbing and Chen, Zhaoming and Wu, Fapu and Zhou, Bijia and Xiong, Hu},
title = {Thioketal-Incorporated Biodegradable Lipid Nanoparticles Deliver mRNA to Ductal Epithelial Cells for Improved Pancreatic Cancer Treatment},
journal = {Journal of the American Chemical Society},
year = {2025},
doi = {10.1021/jacs.5c19387}
}
EUVIMED